Galena Biopharma Announces Launch of New Patient Website: NeuVax.com Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low-to-Intermediate HER2 Expression with NeuVax Treatment) study now enrolling under an FDA approved...

Diageo -- Video Interview LONDON, Sept. 1, 2005 (PRIMEZONE) -- Preliminary results. Indepth interview available now on www.cantos.com with Paul Walsh, Chief Executive, Diageo (LSE:DGE). - Results & outlook - US -...